02Transforming patients' lives
Key products

Key products in other areas

While we aim to lead in medical dermatology, our portfolio of legacy products allows us to help improve the lives of patients with other health issues.

Sativex® Franchise (THC:CBD)

Sativex® is a cannabis-based medicine containing tetrahydrocannabinol (THC) and cannabidiol (CBD) indicated for the improvement of symptoms in adult patients with spasticity due to multiple sclerosis.

Crestor® and Provisacor® (rosuvastatin)

Indicated to help control high blood cholesterol, LDL cholesterol, and triglyceride levels.

Almax® (almagate)

Effective treatment for heartburn and gastric acidity in adults and children over 12 years old.

Ebastel® Franchise (ebastine)

Second-generation antihistamine providing effective relief from allergic rhinitis symptoms.

Sativex® Franchise (THC:CBD)

Sativex® is a cannabis-based medicine containing tetrahydrocannabinol (THC) and cannabidiol (CBD) indicated for the improvement of symptoms in adult patients with spasticity due to multiple sclerosis.

Crestor® and Provisacor® (rosuvastatin)

Indicated to help control high blood cholesterol, LDL cholesterol, and triglyceride levels.

Almax® (almagate)

Effective treatment for heartburn and gastric acidity in adults and children over 12 years old.

Ebastel® Franchise (ebastine)

Second-generation antihistamine providing effective relief from allergic rhinitis symptoms.

Strategic products

Dermatology Products

Ilumetri®

(tildrakizumab)

Netherlands
Norway
UK
Sweden
Czechia
Belgium
Italy
Switzerland
Germany
Austria
Spain
France
Portugal
Poland
Slovakia
Denmark
Ireland
Total Sales:€234.4 MM

Skilarence®

(dimethyl fumarate)

Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Greece
Ireland
Italy
Luxembourg
Netherlands
Norway
South Korea
Spain
Sweden
Switzerland
United Kingdom
Total Sales:€23.1 MM

Klisyri®

(tirbanibulin)

Austria
Belgium
Denmark
Germany
Italy
Liechtenstein
Luxembourg
Netherlands
Spain
Switzerland
United Kingdom
United States
Total Sales:€32.8 MM

Wynzora® Cream®

(calcipotriol betamethasone)

Austria
Denmark
Germany
Italy
Netherlands
Spain
Switzerland
United Kingdom
Total Sales:€33.8 MM

EBGLYSS®

(lebrikizumab)

Germany
UK
Germany
France
Italy
Spain
Switzerland
Austria
Czechia
Denmark
Netherlands
Belgium
Sweden
Norway
Poland
Luxembourg
Total Sales:€110.8 MM

Actikerall® Cream®

(fluorouracil/salicylic acid)

Australia
Austria
Canada
Czech Republic
Denmark
Finland
Germany
Italy
Norway
Portugal
Slovakia
Spain
Sweden
Switzerland
United Kingdom
Total Sales:€6.6 MM

Cordran® Tape®

(flurandrenolide)

United States
Total Sales:€4.9 MM

Solaraze®®

(diclofenac sodium)

Australia
Austria
Denmark
Finland
France
Germany
Iceland
Ireland
Italy
Luxembourg
Norway
Portugal
Spain
Sweden
Switzerland
United Kingdom
Total Sales:€23.6 MM

Seysara®®

(sarecycline)

United States
Total Sales:€22.5 MM

Ciclopoli®®

(ciclopirox)

Germany
France
Spain
Romania
Colombia
Switzerland
South Korea
Italy
Austria
Australia
Portugal
Belgium
Ecuador
Norway
Sweden
New Zealand
Chile
Monaco
Denmark
Peru
Bolivia
Finland
Czech Republic
Hungary
Latvia
Lithuania
Poland
Russia
Slovakia
Total Sales:€50.5 MM

Almirall has direct presence in Spain, Germany, Italy, France, the United Kingdom, Switzerland, Austria, Belgium, Luxembourg, Andorra, Ireland, the Netherlands, Norway, Denmark, Estonia, Finland, Iceland, Lithuania, Sweden, Poland, Portugal, Slovakia, the Czech Republic, China and the United States. In other countries we distribute ourp roducts through local partners.